June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that ... improve the early diagnosis and management of a wide range of debilitating ...
The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...
The INTERCEPT study is being funded to the tune of €38 million (nearly $40 million) over the next five years and is described ...
Irish Examiner on MSN12d
Crohn's Disease and ulcerative colitis: Eating for good gut healthEating a Mediterranean-style diet can help people manage IBD symptoms, and a new cookbook from Crohn's & Colitis Ireland ...
Many with Crohn’s disease or ulcerative colitis sacrifice essential purchases like food and clothing for healthcare, survey ...
Discover how the Mediterranean diet benefits newly diagnosed Crohn’s disease patients by reducing inflammation and improving ...
The findings suggest that lipid composition can direct mRNA-based drugs to target organs, such as the intestines, without passing through the liver.
Takeda is serving as the Industry Lead in the newly launched INTERCEPT project to identify predictive biomarkers for Crohn's ...
The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...
Piper Sandler analyst maintains an Overweight rating on Teva, citing positive feedback on duvakitug's potential in treating ...
Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback